Skip to content
akaturk Academic measurement
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 102
YÖKSİS102 OpenAlex0
Projects 14
Books 14
Proceedings 118

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 38
h-index 11 Percentile in Türkiye: 90 Without large collaborations: h 10 · 1 papers #66 of 1,015 at their university by h-index
i10-index
12
Total citations
380
Top 12% in Türkiye
Per article
10.0
FWCI
1.28
1.00 = world average
World top 1%
0
World top 10%
4

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 94
  • Q1 41
  • Q2 29
  • Q3 13
  • Q4 12
WoS (JCR) 95
  • Q1 27
  • Q2 24
  • Q3 31
  • Q4 14
TR Index TR Index

12 articles

OpenAlex citation percentile
  • Top 1% 0
  • Top 10% 4
  • Avg 69.9%
  • n 40
Other counts

Scopus (SJR)

  • Best Q 94 Q1 41 Q2 29 Q3 12 Q4 12
  • YÖKSİS rows 100

WoS (JCR)

  • Best Q 95 Q1 27 Q2 23 Q3 31 Q4 14
  • YÖKSİS rows 101

TR Index

  • YÖKSİS rows 13 articles

Proceedings

Conference proceedings recorded in YÖKSİS.

Records

Showing 20 / 118

  1. 2015 Adherence to subcutaneous immunotherapy real life data from a large tertiary medical center European Academy of Allergy and Clinical Immunology Congress
  2. 2019 Ailevi Akdeniz ateşi, makrofaj aktivasyon sendromu,Melkersson-Rosenthal sendromlu olgu XX. Ulusal Romatoloji Kongresi
  3. 2018 Omalizumab tedavisinde 9 yıl: tek merkez gerçek yaşam verisi XXV. Ulusal Allerji ve Klinik İmmunoloji Kongresi ve uluslararası katılımlı
  4. Adrenalin Otoenjektör kimlere verilmeli? Ulusal Alerji ve Klinik İmmünoloji Kongresi
  5. 2015 Immediate and non immediate hypersensitivity reaction to single dose moxifloxacin European Academy of Allergy and Clinical Immunology Congress
  6. 2025 hangi testi ne için kullanalım? XXXI. Uluslararası Katılımlı Ulusal Allerji ve Klinik İmmünoloji Kongresi
  7. 2018 Genel anestezik ilaçlarda alerji deri testlerinin geçerliliği XXV. Ulusal Allrji ve Klinik İmmunoloji Kongresi-Uluslararası katılımlı
  8. 2015 Hayati tehlikesi olan nadir görülen bir hastalık sistemik mastositoz İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2015
  9. 2015 Lenalıdomıde Desensıtızatıon In Two Patıents Wıth Two Dıfferent Reactıon Types 5th International Congree on Leukemia Lymphoma Myeloma
  10. 2022 On demad treatmnet from the patients' perspective in real life Bradykinin Symposium
  11. 2020 Evaluation of immediate reactions and cross-reactivity due to metronidazole and ornidazole as antibiotic elicitors EAACI Digital Congress
  12. 2020 Is tetracycline HCL treatment safe in patients with beta-lactam allergy? 06 - 08 JUNE 2020EAACI DIGITAL CONGRESS 2020
  13. 2019 A real life experience of omalizumab: Nine‐year follow‐up of 205 patients in a single center. European Academy of Allergy and Clinical Immunology Congress
  14. 2015 Early presenting fixed drug eruption with different quinolones in a patient European Academy of Allergy and Clinical Immunology Congress
  15. A 5 YEAR PROSPECTIVE, OBSERVATIONAL STUDY OF SUCCESSFUL RED MEAT DESENSITIZATION IN EARLY AND DELAYED-TYPE HYPERSENSITIVITY REACTIONS DUE TO ALPHA-GAL ALLERGY World Allergy Congress 2022
  16. 2019 Mast hücre aktivasyon sendromu mu? anafilaksi mi? Ulusal allerji ve klinik immünoloji kongresi
  17. 2015 Flukonazole bağlı yaygın fiks ilaç döküntüsü Lenfosit transformasyon testi ve hücre içi salınan sitokinlerin ölçülmesi tanıyı doğruluyor XXII. Ulusal Alerji ve Klinik İmmunoloji Kongresi
  18. 2015 Is premedication important to prevent reactions in cluster immunotherapy European Academy of Allergy and Clinical Immunology Congress
  19. 2015 Clinical efficay of Omalizumab in a patient with AERD a case report Molecular and Laboratory Asthma: A course fort the practicing clinician EAACI Allergy School
  20. 2015 Impact of high serum IgE levels on the risk of atherosclerosis in human European Academy of Allergy and Clinical Immunology Congress

Back to academicians